In its effort to "protect" 340B covered entities, the Health Resources and Services Administration is actually hurting them--and the window to correct course is closing quickly.
Bill, great article as usual! I have a question for you. Do you feel like the IRA is going to force this rebate model for 340B? I know only a little about the IRA but I understand there are rebate provisions related to pricing. Is 340B a wildcard in managing that risk?
Thanks, Tim. Yes, I do think 340B is a strong current pushing the rebate model forward. The Medicare transaction facilitator just isn’t a plausible mechanism to effectuate Medicare fair price. The only real alternative is a manufacturer rebate mechanism or some pretty closely similar model.
I feel the ire. But not sure HRSA will look anything like it does today four years from now. Likely ripe for efficiency resizing and a shifts in target beneficiaries under new leadership.
Bill, great article as usual! I have a question for you. Do you feel like the IRA is going to force this rebate model for 340B? I know only a little about the IRA but I understand there are rebate provisions related to pricing. Is 340B a wildcard in managing that risk?
Thanks, Tim. Yes, I do think 340B is a strong current pushing the rebate model forward. The Medicare transaction facilitator just isn’t a plausible mechanism to effectuate Medicare fair price. The only real alternative is a manufacturer rebate mechanism or some pretty closely similar model.
I feel the ire. But not sure HRSA will look anything like it does today four years from now. Likely ripe for efficiency resizing and a shifts in target beneficiaries under new leadership.